Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -97.99% is 120% below its 2-year average of -44.61%, near the low end of its 2-year range (-97.99%–-14.43%).
As of the fiscal period ended Tuesday, June 30, 2026. 55.09% below its 12-month average of -63.18%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -97.99%.
RETURN ON INVESTED CAPITAL (ROIC)
-97.99%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-63.18%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
-55.09%
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-25.40%
median of 416 covered companies
CURRENT VS SECTOR MEDIAN
-285.78%
vs the sector median at left
Aardvark Therapeutics, Inc. Common Stock
Market Cap
$114.24M
Return on Invested Capital (ROIC)
-97.99%
TTM Avg
-63.18%
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$113.77M
Return on Invested Capital (ROIC)
-0.05%
TTM Avg
-44.27%
3Y Avg
-81.25%
5Y Avg
-78.53%
Market Cap
$116.59M
Return on Invested Capital (ROIC)
-192.18%
TTM Avg
-186.03%
3Y Avg
-161.77%
5Y Avg
-220.86%
Market Cap
$111.17M
Return on Invested Capital (ROIC)
-47.54%
TTM Avg
-30.79%
3Y Avg
-47.42%
5Y Avg
-44.72%
Market Cap
$117.43M
Return on Invested Capital (ROIC)
-44.81%
TTM Avg
-53.33%
3Y Avg
-46.90%
5Y Avg
-39.65%
Market Cap
$118.02M
Return on Invested Capital (ROIC)
-87.72%
TTM Avg
-74.88%
3Y Avg
-52.32%
5Y Avg
-62.32%
Market Cap
$118.63M
Return on Invested Capital (ROIC)
-3.19%
TTM Avg
-2.23%
3Y Avg
-1.75%
5Y Avg
1.24%
Market Cap
$109.49M
Return on Invested Capital (ROIC)
-6.84%
TTM Avg
-23.14%
3Y Avg
-32.81%
5Y Avg
-31.36%
Market Cap
$119.09M
Return on Invested Capital (ROIC)
-137.40%
TTM Avg
-133.78%
3Y Avg
-372.93%
5Y Avg
-315.43%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Aardvark Therapeutics, Inc. Common Stock (AARD) | $114.24M | -97.99% | -63.18% | N/A | N/A |
| Coya Therapeutics, Inc. (COYA)vs › | $113.77M | -0.05% | -44.27% | -81.25% | -78.53% |
| Genelux Corporation (GNLX)vs › | $116.59M | -192.18% | -186.03% | -161.77% | -220.86% |
| Black Diamond Therapeutics, Inc. (BDTX)vs › | $111.17M | -47.54% | -30.79% | -47.42% | -44.72% |
| Foghorn Therapeutics Inc. (FHTX)vs › | $117.43M | -44.81% | -53.33% | -46.90% | -39.65% |
| Caribou Biosciences, Inc. (CRBU)vs › | $118.02M | -87.72% | -74.88% | -52.32% | -62.32% |
| BGM Group Ltd. (BGM)vs › | $118.63M | -3.19% | -2.23% | -1.75% | 1.24% |
| Apyx Medical Corporation (APYX)vs › | $109.49M | -6.84% | -23.14% | -32.81% | -31.36% |
| TuHURA Biosciences, Inc. (HURA)vs › | $119.09M | -137.40% | -133.78% | -372.93% | -315.43% |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP)vs › | $108.39M | -101.30% | -45.83% | -127.78% | -123.84% |
ROIC
-98.0%
ROE
-93.4%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -97.99% |
| 2026-03-31 | -85.90% |
| 2025-12-31 | -58.58% |
| 2025-09-30 | -43.65% |
| 2025-06-30 | -29.79% |
| 2025-03-31 | -20.58% |
| 2024-12-31 | -31.39% |
| 2024-09-30 | -19.19% |
| 2024-06-30 | -14.43% |
